Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Bellerophon Therapeutics, Inc. (BLPH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Total revenues  5.65.60.00.00.00.00.00.0
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  5.65.60.00.00.00.00.00.0
            Gross margin  100.0%100.0%      
Selling, general and administrative   [+]6.76.46.05.86.26.17.18.0
Research and development  12.914.516.415.815.113.813.016.0
EBITDA   [+]-14.0-15.2-22.3-21.5-21.2-19.9-20.1-23.9
            EBITDA margin  -247.4%-269.8%      
Depreciation and amortization  0.00.00.10.10.10.10.10.1
EBIT   [+]-14.0-15.3-22.4-21.6-21.3-19.9-20.2-24.0
            EBIT margin  -247.9%-270.6%      
Interest income   0.1   0.0  
Other income (expense), net   [+]0.2 0.10.10.2 0.60.7
Pre-tax income  -13.7-15.1-22.2-21.5-21.1-19.7-19.6-23.3
Income taxes  -1.3-3.7-2.4-2.4-2.4-1.8-1.8-1.8
            Tax rate  9.3% 10.9%11.2%11.5%9.1%9.2%7.7%
Net income  -12.4-11.4-19.8-19.1-18.7-17.9-17.8-21.5
            Net margin  -219.9%-201.6%      
   
Basic EPS   [+]($1.19)($1.17)($2.08)($2.00)($1.96)($1.88)($1.87)($2.37)
Diluted EPS   [+]($1.18)($1.16)($2.08)($2.00)($1.96)($1.88)($1.87)($2.37)
   
Shares outstanding (basic)   [+]10.49.79.59.59.59.59.59.1
Shares outstanding (diluted)   [+]10.59.89.59.59.59.59.59.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy